000 01472 a2200373 4500
005 20250512034427.0
264 0 _c19870513
008 198705s 0 0 eng d
022 _a0007-1188
024 7 _a10.1111/j.1476-5381.1987.tb08970.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAllgaier, C
245 0 0 _aThe adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cFeb 1987
300 _a403-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenosine
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aElectric Stimulation
650 0 4 _aEthylmaleimide
_xantagonists & inhibitors
650 0 4 _aGTP-Binding Proteins
_xphysiology
650 0 4 _aHippocampus
_xdrug effects
650 0 4 _aIn Vitro Techniques
650 0 4 _aNorepinephrine
_xmetabolism
650 0 4 _aPhenylisopropyladenosine
_xpharmacology
650 0 4 _aRabbits
650 0 4 _aReceptors, Purinergic
_xdrug effects
650 0 4 _aTheophylline
_xanalogs & derivatives
650 0 4 _aYohimbine
_xpharmacology
700 1 _aHertting, G
700 1 _aKügelgen, O V
773 0 _tBritish journal of pharmacology
_gvol. 90
_gno. 2
_gp. 403-12
856 4 0 _uhttps://doi.org/10.1111/j.1476-5381.1987.tb08970.x
_zAvailable from publisher's website
999 _c3109607
_d3109607